The filgrastim biosimilar Zarxio, the first approved in the US, can be used to treat patients with acute myelogenous leukemia and bone marrow transplants, among other conditions. A biosimilar form of the rheumatology drug infliximab may be close on its heels.
For many obese adults, diet and exercise are not enough to achieve durable weight loss. Three drugs are approved in the US as adjunctive therapy for obesity management. Weigh in with what you know with answers to these 3 questions.
Media attention to bipolar and Internet-based information lead some people to decide (mistakently) that they have the condition. Correct assessment and affirming reassurance, studies snow, is what patients with mood instability want most.